Cerca Cerca Ricerca avanzata

SOLARO - MANAGEMENT OF SYMPTOMS IN MULTIPLE SCLER.

Solaro C.

Titolo Professionale - Neurologia

giugno 2013
ISBN: 9788821437601
Pagine: 109
Rilegatura: Brossura
Formato: 24 x 17

Disponibile anche in formato eBook

€ 24,00
Descrizione

• This book offers a recent overview on the pathophysiology, the prevalence, and the treatment  of symptoms in Multiple Sclerosis and it gives prominence to a number of the less-acknowledged and challenging symptoms such as pain, mood disturbance, and dysphagia. It also offers an up-to-date account on the most recent advances in the treatment of the more established symptoms such as spasticity, tremor, and urinary disturbance.
• For each of the areas the authors present a comprehensive management plan, which includes an up-to-date description of the evidence base supporting the current therapeutic options.
• Finally, it is clear that, besides the efforts to have drugs that act on the pathogenetic mechanisms of the disease striking its clinical course, we also need treatments that have beneficial effects on the symptoms that persons with MS constantly experience.

Contenuti

CHAPTER 1 Pain
CHAPTER 2 Fatigue
CHAPTER 3 Depression
CHAPTER 4 Dysphagia
CHAPTER 5 Ataxia and tremor
CHAPTER 6 Spasticity
CHAPTER 7 Urinary disorders
CHAPTER 8 Bowel and sexual dysfunction
CHAPTER 9 Considerations on clinical research on symptomatic therapy in MS

Vedi anche
La riabilitazione neuropsicologica
€ 19,00
Colosimo C.
Neuroradiologia
€ 99,00
Vaccaro A.R.
La colonna vertebrale
€ 119,00

Novita' eBooks

Titolo Professionale

Odontoiatria

ebook

Manuale di utilizzo del laser a diodo in odontostomatologia - ebook

€ 66,99

Titolo Professionale

Odontoiatria

ebook

Odontoiatria e patologie sistemiche - ebook

€ 43,26

Titolo Universitario

Psicologia

ebook

L’occupabilità sostenibile - ebook

€ 13,99

Titolo Professionale

Veterinaria

ebook

Ecografia Point-of-Care nel cane e nel gatto - ebook

€ 82,99

Titolo Professionale

Professionale

ebook

Utilizzo coadiuvante dei nootropi nel trattamento di pazienti con declino cognitivo e patologie neurodegenerative

€ 0,00